Skip to main content
. 2019 Nov 6;9:16151. doi: 10.1038/s41598-019-51651-6

Table 4.

Risks for in situ and invasive skin squamous cell cancers in families of any in situ cancer, and risk for any in situ cancers in families of in situ and invasive skin squamous cell cancers.

Cancer site family member RR for in situ skin squamous cell cancer when family member had in situ cancer RR for in situ cancer when family member had in situ skin squamous cell cancer RR for skin squamous cell cancer when family member had in situ cancer RR for in situ cancer when family member had skin squamous cell cancer
Cases RR 95%CI Cases RR 95%CI Cases RR 95%CI Cases RR 95%CI
Cervix 1645 1.03 0.98–1.08 5966 0.93 0.91–0.96 1106 1.13 1.06–1.20 4201 0.98 0.95–1.02
   Male 806 1.04 0.97–1.12 NR 633 1.15 1.06–1.24 NR
   Female 839 1.01 0.95–1.09 As above 473 1.10 1.00–1.21 As above
Other female genital 73 1.38 1.09–1.73 163 1.25 1.06–1.46 46 1.42 1.06–1.90 102 1.13 0.93–1.38
   Male 45 1.69 1.26–2.26 NR 28 1.51 1.04–2.19 NR
   Female 28 1.06 0.73–1.53 As above 18 1.34 0.84–2.13 As above
Upper aerodigestive tract 74 1.48 1.18–1.86 72 1.33 1.05–1.69 44 1.49 1.11–2.00 55 1.44 1.10–1.89
   Male 35 1.45 1.04–2.01 46 1.31 0.98–1.77 26 1.56 1.06–2.29 24 0.96 0.64–1.45
   Female 39 1.52 1.11–2.08 26 1.35 0.91–2.00 18 1.40 0.88–2.23 31 2.33 1.62–3.35
Other male genital 25 1.44 0.97–2.13 37 0.97 0.70–1.35 14 1.35 0.80–2.29 26 1.00 0.68–1.48
   Male 16 1.93 1.18–3.15 As above 9 1.57 0.82–3.01 As above
   Female 9 0.99 0.52–1.90 NR 5 1.10 0.46–2.64 NR
Colorectum 482 1.03 0.94–1.13 651 0.93 0.86–1.00 296 1.06 0.94–1.18 427 0.86 0.78–0.95
   Male 227 0.98 0.86–1.11 352 0.87 0.78–0.97 172 1.07 0.92–1.25 249 0.88 0.77–0.99
   Female 255 1.08 0.95–1.22 299 1.00 0.89–1.13 124 1.04 0.87–1.24 178 0.84 0.72–0.97
Melanoma 517 1.63 1.49–1.78 1371 1.59 1.51–1.68 296 1.54 1.38–1.73 896 1.50 1.40–1.60
   Male 250 1.59 1.40–1.80 651 1.56 1.44–1.69 159 1.45 1.24–1.70 442 1.53 1.39–1.68
   Female 267 1.67 1.48–1.88 720 1.62 1.50–1.75 137 1.67 1.41–1.97 454 1.47 1.34–1.62
Non-Hodgkin lymphoma 28 1.17 0.81–1.70 40 1.09 0.79–1.50 19 1.33 0.85–2.09 25 0.97 0.65–1.44
   Male 12 1.03 0.59–1.82 26 1.20 0.81–1.79 11 1.36 0.75–2.45 13 0.85 0.49–1.48
   Female 16 1.31 0.80–2.14 14 0.93 0.54–1.58 8 1.30 0.65–2.61 12 1.14 0.64–2.03
All (including SCCa) 6424 1.50 1.46–1.55 13348 1.18 1.16–1.20 3677 1.41 1.36–1.46 9009 1.17 1.14–1.19
   Male 3180 1.51 1.45–1.57 3099 1.56 1.51–1.62 2121 1.43 1.36–1.50 2060 1.47 1.41–1.54
   Female 3244 1.50 1.44–1.56 10249 1.10 1.08–1.12 1556 1.39 1.32–1.47 6949 1.10 1.07–1.12

SCCa = skin squamous cell cancer.

RR = relative risk, 95%CI = 95% confidence interval, bold font indicates that the lower limit of 95%CI does not include 1.00.